Lepu Biopharma Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Ziye Sui
Chief executive officer
CN¥8.8m
Total compensation
| CEO salary percentage | 22.1% |
| CEO tenure | 4.1yrs |
| CEO ownership | n/a |
| Management average tenure | 3.4yrs |
| Board average tenure | 3.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥22m |
| Sep 30 2023 | n/a | n/a | -CN¥254m |
| Jun 30 2023 | n/a | n/a | -CN¥487m |
| Mar 31 2023 | n/a | n/a | -CN¥588m |
| Dec 31 2022 | CN¥9m | CN¥2m | -CN¥689m |
| Sep 30 2022 | n/a | n/a | -CN¥766m |
| Jun 30 2022 | n/a | n/a | -CN¥843m |
| Mar 31 2022 | n/a | n/a | -CN¥927m |
| Dec 31 2021 | CN¥12m | CN¥2m | -CN¥1b |
| Dec 31 2020 | CN¥2m | CN¥1m | -CN¥582m |
Compensation vs Market: Ziye's total compensation ($USD1.21M) is above average for companies of similar size in the Hong Kong market ($USD485.88K).
Compensation vs Earnings: Ziye's compensation has been consistent with company performance over the past year.
CEO
Ziye Sui (42 yo)
4.1yrs
Tenure
CN¥8,789,000
Compensation
Dr. Ziye Sui, M.D. Ph.D. had been Non-Executive Director of Star Combo Pharma Ltd since June 21, 2018 until August 24, 2022. She is the Vice President of Lepu Medical Technology (Beijing) Co. Limited. She...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 6.3yrs | no data | 26.11% CN¥ 2.4b | |
| CEO & Director | no data | CN¥8.79m | no data | |
| Co-CEO & Director | no data | CN¥9.29m | no data | |
| CFO & Board Secretary | 3.4yrs | no data | no data | |
| Chief Technology Officer | 3.4yrs | no data | no data | |
| Joint Company Secretary | 3.1yrs | no data | no data |
3.4yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 2157's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 6.3yrs | no data | 26.11% CN¥ 2.4b | |
| CEO & Director | 4.1yrs | CN¥8.79m | no data | |
| Co-CEO & Director | 4yrs | CN¥9.29m | no data | |
| Independent Non-Executive Director | 2.4yrs | CN¥250.00k | no data | |
| Supervisor | 3.4yrs | no data | no data | |
| Non-Executive Director | 4.1yrs | no data | no data | |
| Independent Non-Executive Director | 3.4yrs | CN¥250.00k | no data | |
| Non-Executive Director | 4.1yrs | no data | no data | |
| Non-Executive Director | 4.1yrs | no data | 5.42% CN¥ 495.9m | |
| Independent Non-Executive Director | 3.4yrs | CN¥250.00k | no data | |
| Supervisor | 3.4yrs | no data | no data | |
| Employee Representative Supervisor | 3.4yrs | no data | no data |
3.7yrs
Average Tenure
53.5yo
Average Age
Experienced Board: 2157's board of directors are considered experienced (3.7 years average tenure).